Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 14.12% | -2.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.12% | -2.09% | |||
| Cost of Revenue | 9.50% | -17.53% | |||
| Gross Profit | 16.00% | 5.95% | |||
| SG&A Expenses | -10.45% | -6.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.86% | -8.85% | |||
| Operating Income | 17.73% | 12.93% | |||
| Income Before Tax | 72.07% | -158.14% | |||
| Income Tax Expenses | 81.12% | 13.86% | |||
| Earnings from Continuing Operations | 72.02% | -161.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 72.02% | -161.26% | |||
| EBIT | 17.73% | 12.93% | |||
| EBITDA | 23.41% | 16.43% | |||
| EPS Basic | 72.13% | -162.37% | |||
| Normalized Basic EPS | 17.65% | 15.00% | |||
| EPS Diluted | 72.13% | -162.37% | |||
| Normalized Diluted EPS | 17.65% | 15.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
